Company / Profit Margin
Nuo Therapeutics, Inc. Profit Margin History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-2077.4%
FY2017
5-year range
-2077.4% / -175.0%
FY2013-FY2017
Trend
-72.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has declined for 4 consecutive years, from -175.0% in FY2013 to -2077.4% in FY2017.
Based on SEC 10-K filings.
-2077.4% in FY2017 with a 5-year CAGR of -1890.0%.
Declined from -458.8% to -2077.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -1834.1pp
- 5-Year Change
- -1890.0pp
- 10-Year Change
- -
Key checks
Key Insights
- Nuo Therapeutics, Inc.'s profit margin has declined for 4 consecutive years.
- In FY2017, profit margin decreased 72.3% year-over-year.
- Peak profit margin was recorded in FY2011.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -2077.4% | -72.3% |
| FY2016 | -1205.6% | -162.8% |
| FY2015 | -458.8% | -88.6% |
| FY2014 | -243.3% | -39.0% |
| FY2013 | -175.0% | +6.6% |
| FY2012 | -187.4% | -286.9% |
| FY2011 | -48.4% | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026